Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase Ib |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase 1b clinical trial to evaluate the safety and immunogenicity of recombinant adenoviral serotype 35 (rAd35) and serotype 5 (rAd5) HIV-1 vaccines when given as a heterologous prime-boost regimen or as boosts to a recombinant DNA vaccine in healthy, Ad5-naive and Ad5-exposed, low risk, HIV-1 uninfected adult participants
Description
HVTN 077 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of prime/boost regimens using combinations of VRCHIVADV027-00-VP (rAd35), VRCHIVADV038-00-VP (rAd5), and VRC-HIVDNA044-00-VP (DNA).
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.